Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Colleen McIlvennan to Female

This is a "connection" page, showing publications Colleen McIlvennan has written about Female.

 
Connection Strength
 
 
 
0.538
 
  1. McIlvennan CK, Jones J, Makic M, Meek PM, Chaussee E, Thompson JS, Matlock DD, Allen LA. Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study. Circ Heart Fail. 2021 10; 14(10):e008243.
    View in: PubMed
    Score: 0.034
  2. McIlvennan CK, Matlock DD, Allen LA, Thompson JS, Ranby KW, Sannes TS. Perceived Stress and Depressive Symptoms as Predictors of Decisional Conflict in Dyads Considering a Left Ventricular Assist Device. Circ Cardiovasc Qual Outcomes. 2020 03; 13(3):e006155.
    View in: PubMed
    Score: 0.031
  3. McIlvennan CK, Grady KL, Matlock DD, Helmkamp LJ, Abshire M, Allen LA. End of life for patients with left ventricular assist devices: Insights from INTERMACS. J Heart Lung Transplant. 2019 04; 38(4):374-381.
    View in: PubMed
    Score: 0.028
  4. McIlvennan CK, Matlock DD, Thompson JS, Dunlay SM, Blue L, LaRue SJ, Lewis EF, Patel CB, Fairclough DL, Leister EC, Swetz KM, Baldridge V, Walsh MN, Allen LA. Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial. JACC Heart Fail. 2018 11; 6(11):904-913.
    View in: PubMed
    Score: 0.028
  5. McIlvennan CK. Improving Decision Making for Advanced Heart Failure Patients and Caregivers. J Nurs Adm. 2017 Apr; 47(4):190-191.
    View in: PubMed
    Score: 0.025
  6. McIlvennan CK, Matlock DD. Palliative Care in Heart Failure: Architects Needed. J Card Fail. 2017 02; 23(2):201-203.
    View in: PubMed
    Score: 0.024
  7. McIlvennan CK, Wordingham SE, Allen LA, Matlock DD, Jones J, Dunlay SM, Swetz KM. Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians. J Card Fail. 2017 Sep; 23(9):708-712.
    View in: PubMed
    Score: 0.024
  8. Jurgens PT, Allen LA, Ambardekar AV, McIlvennan CK. Chronic Norovirus Infections in Cardiac Transplant Patients. Prog Transplant. 2017 03; 27(1):69-72.
    View in: PubMed
    Score: 0.024
  9. McIlvennan CK, Lindenfeld J, Kao DP. Sex differences and in-hospital outcomes in patients undergoing mechanical circulatory support implantation. J Heart Lung Transplant. 2017 01; 36(1):82-90.
    View in: PubMed
    Score: 0.024
  10. Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 08; 35(8):1045-8.
    View in: PubMed
    Score: 0.024
  11. McIlvennan CK, Babu AN, Brieke A, Ambardekar AV. Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis? J Cardiothorac Surg. 2016 Apr 11; 11(1):53.
    View in: PubMed
    Score: 0.023
  12. McIlvennan CK, Jones J, Allen LA, Swetz KM, Nowels C, Matlock DD. Bereaved Caregiver Perspectives on the End-of-Life Experience of Patients With a Left Ventricular Assist Device. JAMA Intern Med. 2016 Apr; 176(4):534-9.
    View in: PubMed
    Score: 0.023
  13. McIlvennan CK, Jones J, Allen LA, Lindenfeld J, Swetz KM, Nowels C, Matlock DD. Decision-making for destination therapy left ventricular assist devices: implications for caregivers. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):172-8.
    View in: PubMed
    Score: 0.022
  14. McIlvennan CK, Matlock DD, Narayan MP, Nowels C, Thompson JS, Cannon A, Bradley WJ, Allen LA. Perspectives from mechanical circulatory support coordinators on the pre-implantation decision process for destination therapy left ventricular assist devices. Heart Lung. 2015 May-Jun; 44(3):219-24.
    View in: PubMed
    Score: 0.022
  15. McIlvennan CK, Page RL, Ambardekar AV, Brieke A, Lindenfeld J. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients. J Heart Lung Transplant. 2014 Dec; 33(12):1312-4.
    View in: PubMed
    Score: 0.021
  16. McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot". Circ Cardiovasc Qual Outcomes. 2014 May; 7(3):374-80.
    View in: PubMed
    Score: 0.020
  17. Knoepke CE, Siry-Bove B, Mayton C, Latimer A, Hart J, Allen LA, Daugherty SL, McIlvennan CK, Matlock DD, Khazanie P. Variation in Left Ventricular Assist Device Postdischarge Caregiver Requirements: Results From a Mixed-Methods Study With Equity Implications. Circ Heart Fail. 2022 Aug; 15(8):e009583.
    View in: PubMed
    Score: 0.009
  18. Kanwar MK, McIlvennan CK, Lohmueller LC, Bailey SH, Rogers JG, Teuteberg J, Cowger J. Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices. ASAIO J. 2021 04 01; 67(4):397-404.
    View in: PubMed
    Score: 0.008
  19. Allen LA, Venechuk G, McIlvennan CK, Page RL, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial. Circulation. 2021 02 02; 143(5):427-437.
    View in: PubMed
    Score: 0.008
  20. Venechuk GE, Khazanie P, Page RL, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. Am Heart J. 2020 11; 229:144-155.
    View in: PubMed
    Score: 0.008
  21. Deininger KM, Tsunoda SM, Hirsch JD, Anderson H, Lee YM, McIlvennan CK, Page RL, Tran JN, Aquilante CL. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation. Clin Transplant. 2020 10; 34(10):e14037.
    View in: PubMed
    Score: 0.008
  22. Fendler TJ, McIlvennan CK, Matlock DD, Thompson JS, Chaussee EL, Dunlay SM, LaRue SJ, Raymer DS, Spertus JA, Lewis EF, Patel CB, Walsh MN, Allen LA. Exploring differences between patients who accept, decline, and are deemed ineligible for left ventricular assist device implantation as destination therapy. J Heart Lung Transplant. 2020 07; 39(7):721-724.
    View in: PubMed
    Score: 0.008
  23. Matlock DD, McIlvennan CK, Thompson JS, Morris MA, Venechuk G, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Chaussee EL, Glasgow RE, Walsh MN, Allen LA. Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial. Med Decis Making. 2020 04; 40(3):289-301.
    View in: PubMed
    Score: 0.008
  24. Peters LL, McIlvennan CK, Khazanie P. Evaluation and Management of BK Polyomavirus Viremia in Patients With a Heart Transplant. Prog Transplant. 2019 12; 29(4):367-370.
    View in: PubMed
    Score: 0.008
  25. Kanwar MK, Lohmueller LC, Teuteberg J, Kormos RL, Rogers JG, Benza RL, Lindenfeld J, McIlvennan C, Bailey SH, Murali S, Antaki JF. Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis. ASAIO J. 2019 07; 65(5):436-441.
    View in: PubMed
    Score: 0.007
  26. Warraich HJ, Allen LA, Blue LJ, Chaussee EL, Thompson JS, McIlvennan CK, Flint KM, Matlock DD, Patel CB. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. Am Heart J. 2019 07; 213:91-96.
    View in: PubMed
    Score: 0.007
  27. Kanwar MK, Lohmueller LC, Kormos RL, Teuteberg JJ, Rogers JG, Lindenfeld J, Bailey SH, McIlvennan CK, Benza R, Murali S, Antaki J. A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation. JACC Heart Fail. 2018 09; 6(9):771-779.
    View in: PubMed
    Score: 0.007
  28. Kwon R, Allen LA, Scherer LD, Thompson JS, Abdel-Maksoud MF, McIlvennan CK, Matlock DD. The Effect of Total Cost Information on Consumer Treatment Decisions: An Experimental Survey. Med Decis Making. 2018 07; 38(5):584-592.
    View in: PubMed
    Score: 0.007
  29. Allen LA, McIlvennan CK, Thompson JS, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Fairclough DL, Leister EC, Glasgow RE, Cleveland JC, Phillips C, Baldridge V, Walsh MN, Matlock DD. Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):520-529.
    View in: PubMed
    Score: 0.007
  30. Allen LA, Matlock DD, Shetterly SM, Xu S, Levy WC, Portalupi LB, McIlvennan CK, Gurwitz JH, Johnson ES, Smith DH, Magid DJ. Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure. JAMA Cardiol. 2017 04 01; 2(4):435-441.
    View in: PubMed
    Score: 0.006
  31. Bandle B, Ward K, Min SJ, Drake C, McIlvennan CK, Kao D, Wald HL. Can Braden Score Predict Outcomes for Hospitalized Heart Failure Patients? J Am Geriatr Soc. 2017 Jun; 65(6):1328-1332.
    View in: PubMed
    Score: 0.006
  32. Narayan M, Jones J, Portalupi LB, McIlvennan CK, Matlock DD, Allen LA. Patient Perspectives on Communication of Individualized Survival Estimates in Heart Failure. J Card Fail. 2017 Apr; 23(4):272-277.
    View in: PubMed
    Score: 0.006
  33. Magid M, McIlvennan CK, Jones J, Nowels CT, Allen LA, Thompson JS, Matlock D. Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis. Am Heart J. 2016 10; 180:64-73.
    View in: PubMed
    Score: 0.006
  34. Paine AM, Allen LA, Thompson JS, McIlvennan CK, Jenkins A, Hammes A, Kroehl M, Matlock DD. Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey. J Card Fail. 2016 Nov; 22(11):908-912.
    View in: PubMed
    Score: 0.006
  35. Thompson JS, Matlock DD, McIlvennan CK, Jenkins AR, Allen LA. Development of a Decision Aid for Patients With Advanced Heart Failure Considering a Destination Therapy Left Ventricular Assist Device. JACC Heart Fail. 2015 Dec; 3(12):965-76.
    View in: PubMed
    Score: 0.006
  36. Iacovetto MC, Matlock DD, McIlvennan CK, Thompson JS, Bradley W, LaRue SJ, Allen LA. Educational resources for patients considering a left ventricular assist device: a cross-sectional review of internet, print, and multimedia materials. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):905-11.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)